Richard E Myers

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. pmc Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase
    Richard E Myers
    Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW95EQ, United Kingdom
    J Virol 82:9228-35. 2008
  2. doi request reprint Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance
    Andrew J Buckton
    Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
    J Antimicrob Chemother 62:1191-8. 2008
  3. pmc Phylodynamic and phylogeographic patterns of the HIV type 1 subtype F1 parenteral epidemic in Romania
    Jean L Mbisa
    Virus Reference Department, Microbiology Services, Health Protection Agency, London, United Kingdom
    AIDS Res Hum Retroviruses 28:1161-6. 2012
  4. pmc Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity
    Chris M Parry
    Antiviral Unit, Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW95EQ, United Kingdom
    Antimicrob Agents Chemother 55:1106-13. 2011
  5. ncbi request reprint Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity
    Robert Gifford
    Department of Infection, University College London, UK
    AIDS 20:1521-9. 2006

Collaborators

Detail Information

Publications5

  1. pmc Analysis of natural sequence variation and covariation in human immunodeficiency virus type 1 integrase
    Richard E Myers
    Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW95EQ, United Kingdom
    J Virol 82:9228-35. 2008
    ..The validation of covariation as a predictive tool will be dependent on monitoring the evolution of HIV-1 integrase under drug selection pressure...
  2. doi request reprint Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance
    Andrew J Buckton
    Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
    J Antimicrob Chemother 62:1191-8. 2008
    ..We present the evaluation of a methodology for the genotypic assessment of human immunodeficiency virus type-1 (HIV-1) drug resistance, optimized for use with dried blood spots (DBS)...
  3. pmc Phylodynamic and phylogeographic patterns of the HIV type 1 subtype F1 parenteral epidemic in Romania
    Jean L Mbisa
    Virus Reference Department, Microbiology Services, Health Protection Agency, London, United Kingdom
    AIDS Res Hum Retroviruses 28:1161-6. 2012
    ..Furthermore, phylogeographic analysis suggests that the root location of the parenteral epidemic was Bucharest...
  4. pmc Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity
    Chris M Parry
    Antiviral Unit, Virus Reference Department, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW95EQ, United Kingdom
    Antimicrob Agents Chemother 55:1106-13. 2011
    ....
  5. ncbi request reprint Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity
    Robert Gifford
    Department of Infection, University College London, UK
    AIDS 20:1521-9. 2006
    ..However, it is not clear how reliable standard genotyping of these sequences is for describing HIV-1 genetic variation and for detecting novel genetic variants and epidemiological trends...